Bottmingen, Switzerland

Francesco Hofmann


Average Co-Inventor Count = 13.4

ph-index = 3

Forward Citations = 62(Granted Patents)


Location History:

  • Bottmingen, CH (2002 - 2006)
  • Basel, CH (2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Francesco Hofmann: Innovator in Cancer Treatment

Introduction

Francesco Hofmann is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Hofmann's work focuses on developing personalized therapies and pharmaceutical products aimed at treating neoplastic diseases.

Latest Patents

Hofmann's latest patents include groundbreaking compositions and methods to treat cancer. These innovations provide novel personalized therapies, kits, and methods for treating patients with cancer, particularly those amenable to therapeutic treatment with specific inhibitors. Another significant patent involves N-Aryl (thio) anthranilic acid amide derivatives, which are designed for the treatment of neoplastic diseases that respond to the inhibition of VEGF receptor tyrosine kinase activity. These compounds can be utilized in treating various conditions, including tumor diseases, retinopathy, and age-related macular degeneration.

Career Highlights

Throughout his career, Hofmann has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Schering Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative treatments for cancer.

Collaborations

Hofmann has collaborated with esteemed colleagues such as Karl-Heinz Altmann and Guido Bold. These partnerships have further enhanced his research and development efforts in the field of cancer therapies.

Conclusion

Francesco Hofmann is a distinguished inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…